Hormone Therapy For Menopause Linked To Alzheimer's Hallmark

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 10, 2025.

By Dennis Thompson HealthDay Reporter

MONDAY, March 10, 2025 -- Hormone replacement therapy during menopause appears to be linked to a toxic brain protein that’s a hallmark of Alzheimer’s disease.

Women over 70 had a faster accumulation of tau in their brains if they’d taken hormone therapy for menopause symptoms more than a decade before, according to a new report in Science Advances.

Tau tangles are one of the hallmarks associated with Alzheimer’s, researchers noted.

Researchers did not find a significant difference in their accumulation of amyloid beta, another toxic protein linked to Alzheimer’s.

“Approximately a quarter of currently postmenopausal women who are 70 years and older have a history of HT use and have now entered a critical age of risk for Alzheimer’s disease,” senior researcher Rachel Buckley, a cognitive neuroscientist with Massachusetts General Hospital in Boston, said in a news release.

But researchers found that hormone therapy among younger women did not appear to be linked with increased tau accumulations -- supporting the notion that it should be safe early in menopause.

“Our findings add to the evidence that delaying initiation of hormone therapy, especially in older women, could lead to worse Alzheimer’s outcomes,” Buckley said.

For the study, researchers compared brain imaging from 73 women who’d used hormone therapy an average of 14 years earlier with 73 age-matched women who had not.

The participants underwent PET scans for amyloid beta over an average 4.5 years, and for tau an average 3.5 years.

Women 70 or older who used hormone therapy showed faster tau accumulation in specific regions of their brain, results show.

“Our data indicate that hormone therapy may influence tau accumulation as a function of age, with implications for cognitive decline,” lead researcher Gillian Coughlan with Massachusetts General Hospital said in a news release.

“We hope that our study will help to inform Alzheimer’s disease risk discussions relating to women’s reproductive health and treatment,” Coughlan added.

Sources

  • Mass General Brigham, news release, March 5, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-03-11 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords